Old Web
English
Sign In
Acemap
>
Paper
>
SPS-9Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan
SPS-9Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan
2017
Akihiko Genma
Yoichi Nakanishi
Kazuhiko Nakagawa
Nobuyuki Yamamoto
Takeshi Saito
Yasuhiro Tahara
Yuichiro Ohe
Keywords:
Nivolumab
Oncology
Pathology
Medicine
Interim
Internal medicine
General surgery
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]